Correlation between WOMAC score and hyalrunoic acid levels in knee osteoarthritis

Nishant Raj Sharma, Sudhir Singh, Dharmendra Kumar, Sanjiv Kumar

Abstract


Background: Osteoarthritis, a whole organ disease is diagnosed on clinical and radiological features, but plain radiographs show changes only in moderate to advanced stage of disease. Biochemical marker such as Hyaluronic Acid (HA) is used as a diagnostic tool in early stages. Hyaluronic acid level estimation has limited use in developing world due to cost and availability.

Methods: A case-control study was done to correlate role of WOMAC score and serum Hyaluronic acid levels in knee osteoarthritis. All subjects were asked to fill the WOMAC questionnaire and were subjected to knee radiography. Blood samples of all subjects were tested for serum levels of Hyaluronic acid by Enzyme Linked Immuno-Sorbent Assay (ELISA). The assessment of severity was done by K-L grading of the radiographs.

Results: The mean age in case group was 51.28 ± 7.93 years and in control group was 46.08 ± 4.81 years (P <0.001). A statistically significant difference in WOMAC score, HA levels and K-L grading of cases and controls was found (P <0.001). The results show a mild association of HA (r=0.421), moderate association of age (r=0.570), and strong association of K-L grade (r=0.910) with WOMAC scores and all these associations were highly significant (p<0.001). Multivariate analysis shows only WOMAC score >60 is independently associated with the outcome.

Conclusion: WOMAC scores are significantly associated with knee osteoarthritis and can play a crucial role in identification, gradation and management of patients with knee osteoarthritis and can be used singly along with clinical features in situations where treatment cost and assessment of serum HA levels is of concern.

 


Keywords


WOMAC score, Hyaluronic acid, HA levels, K-L grade, Osteoarthritis, KOA

Full Text:

PDF

References


Jeremie S, Gabriel H, Frances B. Osteoarthritis: pathogenesis, clinical aspects and diagnosis. Eular Compend Rheum Dis. 2009;30:444-63.

Keuttner KE, Golderg VM. Osteoarthritic disorders. In: Keuttner KE, Golderg VM, eds. A Book. 2nd ed. Rosemont: AAOS; 1995: 95-101.

Mangat G, Balakrishnan C, Venkatachalam S, Joshi VR. Pattern of osteoarthritis in India: a hospital based study. J Indian Rheum Assoc. 1995;3(4):125-8.

Garnero P, Rousseau JC, Demas PD. Molecular basis and clinical use of biochemical marker of bone, cartilage, and synovium in joint disease. Arthritis Rheum. 2000;43:953-68.

Garnero P, Piperno M, Gineyts E, Christgau S, Delmas DP, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001;60:619-26.

Rousseau JC, Pierre DD. Biological markers in osteoarthritis. Nat Clinpra Rheum. 2007;3(6):346-56.

Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27-33.

Turan Y, Bal S, Gurgan A, Topac H, Koseoglu M. Serum hyaluronan levels in patients with knee osteoarthritis. Clin Rheumatol. 2007;26(8):1293-8.

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. The American college of rheumatology criteria for the classification and reporting of osteoarthritis of knee. Arthritis Rheum. 1986;29:1039-49.

American College of Rheumatology. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), 2012. Available at: http://www.rheumatology.org/practice/clinical/clinicianresearchers/outcomes-instrumentation/WOMAC.asp.

BioVendor. Product data sheet. TECO hyaluronic acid ELISA kit. Cat no. TE1017, LOT 330213. TECO medical group, Gewerbestr, Switzerland, 2015. Available at: https://www.biovendor.cz/download/7180/Navod_TE1017-2.pdf

Petersson IF, Boegård T, Saxne T, Silman AJ, Svensson B. Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis. 1997;56:493-6.

Singh S, Kumar D, Sharma NR. Role of hyaluronic acid in early diagnosis of knee osteoarthritis. J Clin Diagn Res. 2014;8(12):LC04-7.

Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum. 2005;52(1):105-11.

Davis CR, Karl J, Granell R, Kirwan JR, Fasham J, Johansen J, et al. Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum. 2007;56(12):4038-47.

Kaneko H, Ishijima M, Doi T, Futami I, Liu L, Sadatsuki R, et al. Reference intervals of serum hyaluronic acid corresponding to the radiographic severity of knee osteoarthritis in women. BMC Musculoskel Disord. 2013;14:34.

Golightly YM, Marshall SW, Kraus VB, Renner JB, Villaveces A, Casteel C, et al. Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms? Arthritis Rheum. 2011;63(8):2276-83.

Darwish AF, Hosny S. Abdel-Ghany, Yasser M. El-Sherbini. Diagnostic and prognostic value of some biochemical markers in early knee osteoarthritis. Egypt Rheumatol. 2012;34:1-8.

Singh S, Khanna V. Correlation between clinical and radiological grading of osteoarthritis. Sci J Med Sci. 2014;3(5):320-4.

Kersten P, White PJ, Tennant A. The visual analogue WOMAC 3.0 scale - internal validity and responsiveness of VAS version. BMC Musculoskel Disord. 2010;11:80.